The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

BACKGROUND: The outcome of chemotherapy in breast cancer is strongly influenced by multidrug resistance (MDR). Several surrogate markers of chemoresistance have been identified including - CD24 (cluster differentiation 24) expression, stem cell growth factor (SCF), B-cell lymphocyte protein 2 (Bcl-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelly, Neil D, Hussain, Issam I, Eremin, Jennifer, Eremin, Oleg, El-Sheemy, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413589/
https://www.ncbi.nlm.nih.gov/pubmed/22642642
http://dx.doi.org/10.1186/1475-2867-12-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413589/
https://www.ncbi.nlm.nih.gov/pubmed/22642642
http://dx.doi.org/10.1186/1475-2867-12-21

Ejemplares similares